Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Liver Glycogen on Hypoglycemic Counterregulation
NCT03241706Phase 1Active, not recruiting
- Start
- Aug 2018
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind trial of Fructose Diphosphate Sodium Injection in hypoglycemia (3 arms). Primary endpoints: Epinephrine at 2 hours, Glucagon at 2 hours and 1 more. Started Aug 2018; status: active, not recruiting.
02
Drugs
Fructose Diphosphate Sodium Injection
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT03241706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03241706.